KII Invests in Surv BioPharma for Innovative Cancer Treatment Development Keio Innovation Initiative (KII) invests in Surv BioPharma, a startup from Kagoshima University, enhancing cancer treatment options.

KII Invests in Surv BioPharma for Innovative Cancer Treatment Development #Japan #Cancer_Treatment #Kagoshima #KII #Surv_BioPharma